The t(5;11)(q35;p15.5) translocation resulting in a NUP98‐NSD1 fusion first described in a pediatric AML patient in 2001, is seen in 3% to 7% of pediatric AML cases, and confers a poor prognosis.10 The gene discussed is NSD1; the disease is acute myeloid leukemia.